Literature DB >> 20466289

Second-trimester maternal serum quadruple test for Down syndrome screening: a Taiwanese population-based study.

S W Steven Shaw1, Shin-Yu Lin, Chia-Hui Lin, Yi-Ning Su, Po-Jen Cheng, Chien-Nan Lee, Chih-Ping Chen.   

Abstract

OBJECTIVE: To assess the usefulness of quadruple test screening for Down syndrome in Taiwan.
MATERIALS AND METHODS: Maternal serum concentrations of alpha-fetoprotein, human chorionic gonadotropin, unconjugated estriol, and inhibin A were measured in 21,481 pregnant women from 15 to 20 weeks of gestation.
RESULTS: Of the 21,481 women, 977 returned values greater than the high-risk cut-off value (1 in 270). Most of these women (86.2%) decided to have an invasive procedure for genetic diagnosis. Nine cases of Down syndrome and 19 cases of other chromosomal anomalies were detected prenatally. Two children with Down syndrome were diagnosed after delivery even though a low estimated risk was determined following the quadruple test. The detection rate was 81.8% (nine out of 11 cases), with a 4.4% false-positive rate. The median multiple of the median value for a-fetoprotein, human chorionic gonadotropin, unconjugated estriol and inhibin A were 0.87, 2.34, 0.77 and 2.16, respectively, in affected cases.
CONCLUSION: This is the first study of the quadruple test for Down syndrome in a Chinese population. Our findings suggested that the second-trimester quadruple test provides an effective screening tool for Down syndrome in Taiwan.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20466289     DOI: 10.1016/S1028-4559(10)60005-8

Source DB:  PubMed          Journal:  Taiwan J Obstet Gynecol        ISSN: 1028-4559            Impact factor:   1.705


  6 in total

1.  Ethnic-specific reference range affects the efficacy of quadruple test as a universal screening for Down syndrome in a developing country.

Authors:  Savitree Pranpanus; Ounjai Kor-Anantakul; Thitima Suntharasaj; Chitkasaem Suwanrath; Tharangrut Hanprasertpong; Ninlapa Pruksanusak; Chusana Petpichetchian; Manaphat Suksai; Natthicha Chainarong; Rapphon Sawaddisan
Journal:  PLoS One       Date:  2021-05-13       Impact factor: 3.240

2.  Significance of data analysis in the quality control of prenatal screening for Down syndrome.

Authors:  Yahong Li; Xiaojuan Zhang; Dongyang Hong; Xianwei Guan; Shaolei Lv; Yun Sun; Tao Jiang
Journal:  Biomed Rep       Date:  2018-03-15

3.  Pregnant women's attitudes and decision-making regarding prenatal Down syndrome screening and diagnosis: scale development and validation.

Authors:  Wei-Hsiang Huang; Shu-Fang Shih; Chen-Li Lin; Chieh-Hsing Liu
Journal:  BMC Pregnancy Childbirth       Date:  2020-07-14       Impact factor: 3.007

4.  Prenatal diagnosis of 4953 pregnant women with indications for genetic amniocentesis in Northeast China.

Authors:  Rulin Dai; Yang Yu; Qi Xi; Xiaonan Hu; Haibo Zhu; Ruizhi Liu; Ruixue Wang
Journal:  Mol Cytogenet       Date:  2019-11-06       Impact factor: 2.009

5.  Performance of second-trimester maternal biochemistry screening (quadruple test vs. triple test) for trisomy 21: An Indian experience.

Authors:  Aanchal Sablok; Akshatha Sharma; Chanchal Singh Ahmed; Anita Kaul
Journal:  Indian J Med Res       Date:  2021-05       Impact factor: 5.274

6.  The impact of Down syndrome screening on Taiwanese Down syndrome births: a nationwide retrospective study and a screening result from a single medical centre.

Authors:  Shin-Yu Lin; Chia-Jung Hsieh; Yi-Li Chen; S W Steven Shaw; Sheng-Wen Steven Shaw; Ming-Wei Lin; Pau-Chung Chen; Chien-Nan Lee
Journal:  PLoS One       Date:  2013-09-20       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.